Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

NCT05722015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023) Phoenix, Arizona, United States
  • Clermont Oncology Center ( Site 0018) Clermont, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0010) Orange City, Florida, United States
  • University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) Chicago, Illinois, United States
View all 110 locations
View Trial Details
Active, not recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details
Active, not recruiting

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

NCT01770418

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Florida Proton Therapy Institute Jacksonville, Florida, United States
  • Northwestern Medicine Chicago Proton Center Warrenville, Illinois, United States
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • Princeton ProCure Management LLC Somerset, New Jersey, United States
View Trial Details
Active, not recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Active, not recruiting

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

NCT03907852

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View Trial Details
Active, not recruiting

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

NCT05796089

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
View Trial Details
Active, not recruiting

CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC

NCT04495153

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UConn Health Farmington, Connecticut, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions